Hungarian AI startup Deligo secures $3M for its visual recognition technology
Hungarian visual recognition software developer Deligo has secured $3 million in a round led by Frontline Ventures. Interactive Venture Partners, and Grep VC also participated in the investment alongside various angel investors.
London-based insurtech startup Eleos raises $4M in a seed round
London-based life insurance startup Eleos has raised a $4 million seed funding led by Fuel Ventures and Indico Capital. The investment came just six months after Eleos closed its $750,000 pre-seed round.
Dutch startup SLAM Orthopedic raises €2M led by Rising Star Ventures Partners
Delft-based modern provider of medical devices, SLAM Orthopedic, has raised a €2 million seed investment to introduce its fracture therapy sensor onto the market in Europe.
Swiss startup mimic raises $2.5M for AI-powered robotic hands
Zurich-based startup mimic has raised $2.5 million in a pre-seed round led by Swiss investor Founderful.
Ukrainian SID Venture Partners invests in three US-based startups
Ukrainian venture capital firm SID Venture Partners has invested in three American-founded startups, including Iris Finance, Relari, and Vendora.
US software provider Cin7 acquires Inventoro, a Czech AI forecasting company
Cin7 has acquired Inventoro, Czech AI-driven sales forecasting company. This acquisition marks the first live exit from Presto Ventures’ second fund, Presto II.
German digital fertility clinics Ovom Care raises €4.8M to expand across Europe
Berlin-based fertility care startup Ovom Care has raised a €4.8 million seed round to develop Ovom Technology Ecosystem and expand its hybrid care model across Europe.
Italian martech Glaut raises $1.4M in pre-seed round led by Founders Fund
Milan-based martech startup Glaut has raised $1.4 million in a pre-seed round led by the Italian Founders Fund.
French medtech startup Klineo raises €2M round led by Bpifrance
Paris-based medtech Klineo has raised €2 million. The investment will enable the startup to improve access to clinical trials for cancer patients and expand to Europe and the US.